Opioid rotation in pain treatment. A case report;Die opioidrotation in der schmerztherapie. Beschreibung anhand eines fallberichts

Anaesthesist

Volumn 51, Issue 1, 2002, Pages 28-32

  Kefalianakis, F ^a   Kugler, M ^a   Van der Auwera, R ^a   Kugler, G ^a  

^a KLINIKUM LUDWIGSBURG   (Germany)

Author keywords

Case report; Opioid rotation; Pain treatment

Indexed keywords

OPIATE AGONIST;

ANALGESIA; ARTICLE; CASE REPORT; DRUG USE; HUMAN; PAIN; TREATMENT INDICATION; TREATMENT PLANNING;

ADMINISTRATION, CUTANEOUS; CHRONIC DISEASE; FENTANYL; HUMANS; HYDROMORPHONE; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; MORPHINE; NEOPLASMS; PAIN;

EID: 0036162933     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101-002-8368-9     Document Type: Article

References (29)

1. New approaches to pain control in patients with cancer
2. Interaktionen zentraler analgetika vom typ opioid
3. Systemic analgesics
4. Changing pattern of agitated impaired mental status in patients with advanced cancer: Association with cognitive monitoring, hydration and opioid rotation
5. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone and morphine
6. Morphine-like drugs inhibit stimulation by E prostaglandins of cyclic AMP formation by rat brain homogenate
7. Reduction in constipation and laxative requirements following opioid rotation to methadone: A report of four cases
8. The NMDA receptor antagonist, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the μ-opioid morphine but not to κ-opioids
9. Rezeptorinteraktion von agonisten, antagonisten und partiellen agonisten
10. The use of intermittent subcutaneous injections of oxycodone for opioid rotation in patients with cancer pain
11. Differences in the ratios of morphine to methadone in patients with neuropathic pain versus non-neuropathic pain
12. Medikamentöse therapie
13. Dose ratio between morphine and hydromorphone in patients with cancer pain: A retrospective study
14. Kinetik und verabreichungstechniken
15. Opioid hyperexcitability: The application of alternate opioid therapy
16. Opioid rotation for cancer pain: Rationale and clinical aspects
17. Dissociation of μ opioid tolerance from receptor down-regulation in rat spinal cord
18. Effects of intrathecal NMDA and non-NMDA antagonists on acute thermal nociception and their interaction with morphine
19. Managing cancer pain poorly responsive to systemic opioid therapy
20. Constitutive activation of μ-opioid receptor: A novel paradigm of receptor regulation in narcotic analgesia, tolerance and dependence
21. Methadone titration in opioid-resistant cancer pain
22. Opioid rotation for toxicity reduction in terminal cancer patients
23. Grundsätze bei der therapie chronischer tumorschmerzen
24. Stufenschema, betäubungsmittelverordnung
25. Opioid rotation in chronic non-malignant pain patients. A retrospective study
26. Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614: Assessment of opioid receptor changes
27. Individualized use of methadone and opioid rotation in the comprehensive management of cancer pain associated with poor prognostic indicators
28. Direct inhibition of the N-methyl-D-aspartate receptor channel by high concentrations of opioids
29. Validation of World Health Organisation guidelines for cancer pain relief: A 10-year prospective study